Israeli telehealth company Tytocare receives CE mark approval
Netanya-based telehealth company Tyto Care which specializes in incorporating connected devices into telemedicine encounters has received the CE Mark approval for its telehealth solution in Europe.
Netanya, Isreal telemedicine company Tyto Care, which offers solutions that give remote doctors every tool that would be available during an in-person visit like the stethoscope, otoscope, basal thermometer, and a digital camera gets approval from the CE Mark. This approval will help the company successfully expanded its offerings and spread it’s telehealth services in the European market. The tools are designed such that the patients can self-guide themselves, examine themselves on their own and then send them to a doctor or a clinician during a live video chat.
The CEO and co-founder of Tyro Care, Dedi Gilad, told the media that receiving CE mark approval was a milestone for the company and a major step in the company’s continued strategic expansion primarily into Europe and various other markets as well. He further said that the European doctors struggle to keep up with the rise of chronic illnesses and the increasing demands of the ageing population and Tyto Care was working towards reducing this burden of theirs.
He said that the company would carry out this service by replicating the quality of in-person doctors’ visits without any barriers of wait time, transportation and others.
The CEO also said that the company was looking forward to exploring partnerships with other European companies to provide the critical missing link and modify the delivery of conventional primary care.
In the month of January, the company raised $25 million led by PingAn, a Chinese Insurance company and its Global Voyager Fund. Walgreens, Cambia Health Solutions, OrbiMed, LionBird, and Fosun Pharm were the other companies that helped raise funds to launch their services in the Asian and European markets. This Israeli company has plans of expanding their telehealth devices and services to China by building a strategic relationship with PingAn.
The company thinks telehealth can extend specialist’s reach to patients homes and is a more convenient option to recover the revenue lost by the emergency care of the healthcare industry. Tyro Care has planned an exhibition in Dusseldorf, Germany at the leading international trade for the medical sector, MEDICA 2018. This exhibition is set to take place on the 15th of November 2018 and will continue until the 15th of the month.
In 2016, the company gained the US Food and Drug Administration (FDA) clearance for its digital stethoscope and was also granted 510K by the FDA. This device was a part of the advanced set of examination tools in the telehealth world.
The company in August 2018 gained clearance from the Health Canada, the Canadian government department responsible for national public health.
This approval from the Canadian government made the company’s telehealth solution available to Canadian consumers and other professionals.
Now since this solution is available in Europe, the European consumers interested in this service can sign up for a waitlist. The company is yet to decide on the price ranges for these services.
Image credit: www.tytocare.com
